Viridian Therapeutics (VRDN)
NASDAQ:VRDN
Want to see VRDN full AI Analyst Report?
Viridian Therapeutics (VRDN) Ownership Overview
3.88% Insiders
27.35% Mutual Funds
1.09% Other Institutional Investors
16.10% ETFs
51.57% Public Companies and Individual Investors
The ownership structure of Viridian Therapeutics (VRDN) stock is a mix of institutional, retail, and individual investors. Approximately 44.55% of the company’s stock is owned by Institutional Investors, 3.88% is owned by Insiders, and 51.57% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 27, 2025 | xxxxxxxxxxxxx | $9999990 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $61358619 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $4668000 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $55402438 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $94688917 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,910,967 | Institution | 4.79% | 65,905,177 | |
| 3,914,458 | Institution | 3.82% | 52,532,026 | |
| 3,914,458 | Insider | 3.82% | 52,532,026 | |
| 3,820,704 | Institution | 3.73% | 51,273,848 | |
| 3,712,010 | Institution | 3.62% | 49,815,174 | |
| 3,374,944 | Institution | 3.29% | 45,291,748 | |
| 3,282,464 | Institution | 3.20% | 44,050,667 | |
| 3,196,141 | Institution | 3.12% | 42,892,212 | |
| 3,105,825 | Institution | 3.03% | 41,680,172 | |
| 3,042,703 | Institution | 2.97% | 40,833,074 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,820,704 | Institution | 3.73% | 51,273,848 | |
| 3,712,010 | Institution | 3.62% | 49,815,174 | |
| 3,282,464 | Institution | 3.20% | 44,050,667 | |
| 2,645,928 | Institution | 2.58% | 35,508,354 | |
| 1,270,795 | Institution | 1.24% | 17,054,069 | |
| 1,058,110 | Institution | 1.03% | 14,199,836 | |
| 1,014,786 | Institution | 0.99% | 13,618,428 | |
| 968,594 | Institution | 0.95% | 12,998,531 | |
| 923,711 | Institution | 0.90% | 12,396,202 | |
| 849,680 | Institution | 0.83% | 11,402,706 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,118,860 | Institution | 3.04% | 61,004,902 | |
| 2,940,673 | Institution | 2.87% | 39,640,272 | |
| 1,911,685 | Institution | 1.87% | 25,654,813 | |
| 948,317 | Institution | 0.93% | 18,549,081 | |
| 827,387 | Institution | 0.81% | 11,004,247 | |
| 827,387 | Institution | 0.81% | 11,004,247 | |
| 827,387 | Institution | 0.81% | 11,004,247 | |
| 527,435 | Institution | 0.51% | 7,078,178 | |
| 411,235 | Institution | 0.40% | 5,543,448 | |
| 400,541 | Institution | 0.39% | 7,834,582 |
FAQ
Who Owns Viridian Therapeutics (VRDN)?
According to the latest TipRanks data, approximately 1.09% of the company's stock is held by institutional investors, 3.88% is held by insiders, and 51.57% is held by retail investors.
What percentage of Viridian Therapeutics (VRDN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.09% of Viridian Therapeutics (VRDN) stock is held by institutional investors.
What percentage of Viridian Therapeutics (VRDN) stock is held by retail investors?
According to the latest TipRanks data, approximately 51.57% of Viridian Therapeutics (VRDN) stock is held by retail investors.
Who owns the most shares of Viridian Therapeutics (VRDN)?
Vanguard owns the most shares of Viridian Therapeutics (VRDN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.